基于评分的原位肝移植心血管风险预测模型:CAR-OLT评分
在1024例2002—2011年间首次接受原位肝移植的18—75岁连续患者中,开发了预测移植后1年主要心血管并发症的评分模型;主要心血管并发症发生329例(32.1%),评分的C统计量为0.78(偏差校正C统计量0.77),校准良好(Hosmer-Lemeshow P=0.33)。
要点
- CAR-OLT评分用于预测原位肝移植术后1年主要心血管并发症。
- 1,024例首次原位肝移植受者中,329例(32.1%)发生主要心血管并发症。
- 评分C统计量0.78(偏差校正0.77),校准Hosmer-Lemeshow P=0.33。
核心结论
- 基于评分的风险评分可识别原位肝移植术后发生心血管并发症风险较高的患者,该评分可能有助于识别需要进一步风险分层或其他管理策略以改善肝移植术后心血管结局的候选者。
研究设计与样本
- 在一家三级教学医院2002—2011年间接受首次原位肝移植的1,024例18—75岁连续患者队列中,开发基于评分的预测模型(心血管风险原位肝移植风险评分)。
- 采用bootstrap方法获得最终模型回归系数的偏差校正95%置信区间。
主要发现
- 1,024例首次原位肝移植受者中,主要心血管并发症发生于329例(32.1%)。
- 纳入模型的变量包括术前受者年龄、性别、种族、就业状态、教育状态、肝细胞癌病史、糖尿病、心力衰竭、心房颤动、肺动脉或体循环高血压及呼吸衰竭。
- 评分区分度C统计量=0.78,偏差校正C统计量=0.77,优于其他已发表的手术后心血管疾病发病和死亡风险模型,校准良好(Hosmer-Lemeshow P=0.33)。
关键数值与推荐
- 主要结局为1年主要心血管并发症,定义为心血管原因死亡或重大心血管事件住院(心肌梗死、血运重建、心力衰竭、心房颤动、心脏骤停、肺栓塞和/或卒中)。
临床怎么用
- 该评分可用于识别原位肝移植术后心血管并发症风险较高的患者(评分可在www.carolt.us获取),并可能有助于识别需要进一步风险分层或其他管理策略以改善肝移植术后心血管结局的候选者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Cardiovascular disease (CVD) complications are important causes of morbidity and mortality after orthotopic liver transplantation (OLT). There is currently no preoperative risk-assessment tool that allows physicians to estimate the risk for CVD events following OLT. We sought to develop a point-based prediction model (risk score) for CVD complications after OLT, the Cardiovascular Risk in Orthotopic Liver Transplantation risk score, among a cohort of 1,024 consecutive patients aged 18-75 years who underwent first OLT in a tertiary-care teaching hospital (2002-2011). The main outcome measures were major 1-year CVD complications, defined as death from a CVD cause or hospitalization for a major CVD event (myocardial infarction, revascularization, heart failure, atrial fibrillation, cardiac arrest, pulmonary embolism, and/or stroke). The bootstrap method yielded bias-corrected 95% confidence intervals for the regression coefficients of the final model. Among 1,024 first OLT recipients, major CVD complications occurred in 329 (32.1%). Variables selected for inclusion in the model (using model optimization strategies) included preoperative recipient age, sex, race, employment status, education status, history of hepatocellular carcinoma, diabetes, heart failure, atrial fibrillation, pulmonary or systemic hypertension, and respiratory failure. The discriminative performance of the point-based score (C statistic = 0.78, bias-corrected C statistic = 0.77) was superior to other published risk models for postoperative CVD morbidity and mortality, and it had appropriate calibration (Hosmer-Lemeshow P = 0.33). CONCLUSION: The point-based risk score can identify patients at risk for CVD complications after OLT surgery (available at www.carolt.us); this score may be useful for identification of candidates for further risk stratification or other management strategies to improve CVD outcomes after OLT. (Hepatology 2017;66:1968-1979).
引用
- VanWagner LB, Ning H, Whitsett M, et al. A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: The CAR-OLT score. Hepatology. 2017. PMID: 28703300. doi:10.1002/hep.29329
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。